Inorganic and Nano-Metal Chemistry ( IF 1.4 ) Pub Date : 2020-06-05 , DOI: 10.1080/24701556.2020.1769668 Mingjun Sun 1 , Yuying Hou 2 , Xinjuan Wang 3 , Ting-Ting Li 4 , Wenjie Cao 5 , Xiaofa Zhang 6
Abstract
By using a mixed-ligand approach, two new coordination polymers with the chemical formula of {[Zn(L)(ip)·H2O]8}n (1, H2ip = isophthalic acid and L = 1,1’-(2-methylpropane-1,3-diyl)bis(1H-benzo[d]imidazole)) and {[Ni(L)(tdc)·2H2O]2}n (2, H2tdc = 2,5-thiophenedicarboxylic acid) have been hydrothermally synthesized and structurally characterized by single-crystal X-ray diffraction analyses, powder X-ray diffraction, thermogravimetric analysis and elemental analysis. In addition, in vitro anticancer activity of compounds 1 and 2 on four human ovarian cancer cells (CoC1, A2780, 3AO and OVCAR) was further determined. The results showed that compared with their organic ligands, the two compounds displayed efficient antitumor activity.
中文翻译:
两种具有抗卵巢癌活性的新型Zn(II)和Ni(II)配位聚合物的合成和晶体结构
通过使用混合配体方法,化学式为{[Zn(L)(ip)·H 2 O] 8 } n(1,H 2 ip =间苯二甲酸,L = 1,1' -(2-甲基丙烷-1,3-二基)双(1H-苯并[d]咪唑))和{[Ni(L)(tdc)·2H 2 O] 2 } n(2,H 2 tdc = 2,已经通过水热合成并通过单晶X射线衍射分析,粉末X射线衍射,热重分析和元素分析对其结构进行了表征。此外,在体外的化合物的抗癌活性1和2进一步确定在四个人卵巢癌细胞(COC1,A2780,3AO和OVCAR)。结果表明,与它们的有机配体相比,这两种化合物均显示出有效的抗肿瘤活性。